Page last updated: 2024-10-20

urea and Lung Neoplasms

urea has been researched along with Lung Neoplasms in 78 studies

pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.

Lung Neoplasms: Tumors or cancer of the LUNG.

Research Excerpts

ExcerptRelevanceReference
"Low-dose landiolol can be effective quickly and used safely in patients who develop atrial fibrillation after pulmonary resection for lung cancer."7.77Efficacy of low-dose landiolol, an ultrashort-acting β-blocker, on postoperative atrial fibrillation in patients undergoing pulmonary resection for lung cancer. ( Funakoshi, Y; Maeda, H; Maekura, R; Nojiri, T; Okumura, M; Takeuchi, Y; Yamamoto, K, 2011)
"Lung adenomas were induced in strain A mice by chronic treatment with N-nitroso compounds (given in drinking water) and with amines or ureas in food plus NaNO2 in drinking water."7.65Induction of mouse lung adenomas by amines or ureas plus nitrite and by N-nitroso compounds: effect of ascorbate, gallic acid, thiocyanate, and caffeine. ( Cardesa, A; Mirvish, SS; Shubik, P; Wallcave, L, 1975)
" Dose-limiting toxicity of CP-547,632 250 mg by mouth daily in combination with paclitaxel and carboplatin was grade 3 rash and grade 3 diarrhea despite medical intervention."5.12A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC). ( Cohen, RB; Cosgriff, TM; Eisenberg, PD; Hainsworth, JD; Healey, D; Langer, CJ; Liau, K; Madajewicz, S; Pierce, K; Simon, GR; Xu, H, 2007)
"Low-dose landiolol can be effective quickly and used safely in patients who develop atrial fibrillation after pulmonary resection for lung cancer."3.77Efficacy of low-dose landiolol, an ultrashort-acting β-blocker, on postoperative atrial fibrillation in patients undergoing pulmonary resection for lung cancer. ( Funakoshi, Y; Maeda, H; Maekura, R; Nojiri, T; Okumura, M; Takeuchi, Y; Yamamoto, K, 2011)
"Lung adenomas were induced in strain A mice by chronic treatment with N-nitroso compounds (given in drinking water) and with amines or ureas in food plus NaNO2 in drinking water."3.65Induction of mouse lung adenomas by amines or ureas plus nitrite and by N-nitroso compounds: effect of ascorbate, gallic acid, thiocyanate, and caffeine. ( Cardesa, A; Mirvish, SS; Shubik, P; Wallcave, L, 1975)
"In patients with COPD, only serum creatinine was higher (81."1.48Renal Impairment Hampers Bisphosphonate Treatment in a Quarter of Lung Cancer Patients with Bone Metastasis. ( Döme, B; Fábián, K; Fejes, D; Kakuk, T; Moldvay, J; Pipek, O; Prés, L; Puskás, R; Rojkó, L; Szállási, Z; Szegedi, Z, 2018)
"Lung cancer is one of the most frequently diagnosed malignancies in the world, thus developing novel anticancer reagents for lung cancer treatment is critical."1.48UNBS5162 inhibits the proliferation of human A549 non-small-cell lung cancer cells by promoting apoptosis. ( Gao, Y; Liu, C; Xing, J, 2018)
"Lung cancer is the most common malignancy and is the leading cause of cancer-related death worldwide."1.46[Relationships between Serum Albumin and Urea Level and the Clinical Pathological Characteristics and Survival Time in Patients with Lung Cancer]. ( Li, L; Li, W; Li, Y; Zhang, L, 2017)
"Breast cancer is the most common malignant disease occurring in women and represents a substantial proportion of the global cancer burden."1.43Suppression of the metastatic spread of breast cancer by DN10764 (AZD7762)-mediated inhibition of AXL signaling. ( Cho, JH; Choi, HG; Kim, CY; Kim, D; Kim, HK; Kim, ND; Ko, E; Lee, C; Lee, SH; Nan, HY; Park, JS; Son, JB; Yoon, S, 2016)
"Lung cancer is the leading cause of cancer deaths, and effective treatments are urgently needed."1.43MEK inhibitors block growth of lung tumours with mutations in ataxia-telangiectasia mutated. ( Bago-Horvath, Z; Fece de la Cruz, F; Haura, EB; Katz, AM; Kerzendorfer, C; Konopka, T; Loizou, JI; Mair, B; Mazouzi, A; Muellner, MK; Nagy-Bojarszky, K; Nijman, SM; Paz, K; Smida, M; Suchankova, T; Uras, IZ, 2016)
" Lung tumor yield was examined on the 84th day and 140 days after B(a)P dosing and 240 days after NTCU treatment."1.34Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice. ( Afaq, F; Khan, N; Kim, K; Kweon, MH; Mukhtar, H, 2007)
"Lymphomas were seen only at the higher dose when the animals were were young, at the beginning of the test."1.26Large bowel carcinogenesis in mice and rats by several intrarectal doses of methylnitrosourea and negative effect of nitrite plus methylurea. ( Maronpot, RR; Narisawa, T; Weisburger, JH; Wong, CQ, 1976)

Research

Studies (78)

TimeframeStudies, this research(%)All Research%
pre-199038 (48.72)18.7374
1990's2 (2.56)18.2507
2000's6 (7.69)29.6817
2010's25 (32.05)24.3611
2020's7 (8.97)2.80

Authors

AuthorsStudies
Wu, K2
He, R1
Li, Z3
Qiu, K1
Xiao, G1
Peng, L1
Meng, X1
Zheng, C1
Zhang, Z1
Cai, Q2
Kothayer, H1
Rezq, S1
Abdelkhalek, AS1
Romero, DG1
Elbaramawi, SS1
Zorc, B1
Rajić, Z1
Perković, I1
Yamamoto, H1
Hamasaki, T1
Onda, K1
Nojiri, T2
Aragaki, M1
Horie, N1
Sato, N1
Hida, Y1
Zukotynski, KA1
Jadvar, H1
Potvin, K1
Cho, SY1
Kim, CK1
Winquist, E1
Liu, B1
Chen, W3
Li, H5
Li, F3
Jin, X1
Li, Q3
Nguépy Keubo, FR1
Mboua, PC1
Djifack Tadongfack, T1
Fokouong Tchoffo, E1
Tasson Tatang, C1
Ide Zeuna, J1
Noupoue, EM1
Tsoplifack, CB1
Folefack, GO1
Kettani, M1
Bandelier, P1
Huo, J1
Yu, D1
Arulsamy, N1
AlAbbad, S1
Sardot, T1
Lekashvili, O1
Decato, D1
Lelj, F1
Alexander Ross, JB1
Rosenberg, E1
Nazir, H1
Muthuswamy, N1
Louis, C1
Jose, S1
Prakash, J1
Buan, MEM1
Flox, C1
Chavan, S1
Shi, X1
Kauranen, P1
Kallio, T1
Maia, G1
Tammeveski, K1
Lymperopoulos, N1
Carcadea, E1
Veziroglu, E1
Iranzo, A1
M Kannan, A1
Arunamata, A1
Tacy, TA1
Kache, S1
Mainwaring, RD1
Ma, M1
Maeda, K1
Punn, R1
Noguchi, S1
Hahn, S3
Iwasa, Y3
Ling, J2
Voccio, JP2
Kim, Y3
Song, J3
Bascuñán, J2
Chu, Y1
Tomita, M1
Cazorla, M1
Herrera, E1
Palomeque, E1
Saud, N1
Hoplock, LB1
Lobchuk, MM1
Lemoine, J1
Li, X11
Henson, MA1
Unsihuay, D1
Qiu, J1
Swaroop, S1
Nagornov, KO1
Kozhinov, AN1
Tsybin, YO1
Kuang, S1
Laskin, J1
Zin, NNINM1
Mohamad, MN1
Roslan, K1
Abdul Wafi, S1
Abdul Moin, NI1
Alias, A1
Zakaria, Y1
Abu-Bakar, N1
Naveed, A1
Jilani, K1
Siddique, AB1
Akbar, M1
Riaz, M1
Mushtaq, Z1
Sikandar, M1
Ilyas, S1
Bibi, I1
Asghar, A1
Rasool, G1
Irfan, M1
Li, XY2
Zhao, S1
Fan, XH1
Chen, KP1
Hua, W1
Liu, ZM1
Xue, XD1
Zhou, B1
Zhang, S2
Xing, YL1
Chen, MA1
Sun, Y1
Neradilek, MB1
Wu, XT1
Zhang, D2
Huang, W1
Cui, Y1
Yang, QQ1
Li, HW1
Zhao, XQ1
Hossein Rashidi, B1
Tarafdari, A1
Ghazimirsaeed, ST1
Shahrokh Tehraninezhad, E1
Keikha, F1
Eslami, B1
Ghazimirsaeed, SM1
Jafarabadi, M1
Silvani, Y1
Lovita, AND1
Maharani, A1
Wiyasa, IWA1
Sujuti, H1
Ratnawati, R1
Raras, TYM1
Lemin, AS1
Rahman, MM1
Pangarah, CA1
Kiyu, A1
Zeng, C2
Du, H1
Lin, D1
Jalan, D1
Rubagumya, F1
Hopman, WM1
Vanderpuye, V1
Lopes, G1
Seruga, B1
Booth, CM1
Berry, S1
Hammad, N1
Sajo, EA1
Okunade, KS1
Olorunfemi, G1
Rabiu, KA1
Anorlu, RI1
Xu, C2
Xiang, Y1
Xu, X1
Zhou, L2
Dong, X1
Tang, S1
Gao, XC1
Wei, CH1
Zhang, RG1
He, Y1
Tong, F1
Dong, JH1
Wu, G1
Dong, XR1
Tang, X1
Tao, F1
Xiang, W1
Zhao, Y2
Jin, L1
Tao, H1
Lei, Y1
Gan, H1
Huang, Y1
Chen, Y4
Chen, L3
Shan, A1
Zhao, H2
Wu, M2
Ma, Q1
Wang, J4
Zhang, E1
Zhang, J3
Li, Y8
Xue, F1
Deng, L1
Liu, L2
Yan, Z2
Wang, Y2
Meng, J1
Chen, G3
Anastassiadou, M1
Bernasconi, G1
Brancato, A1
Carrasco Cabrera, L1
Greco, L1
Jarrah, S1
Kazocina, A1
Leuschner, R1
Magrans, JO1
Miron, I1
Nave, S1
Pedersen, R1
Reich, H1
Rojas, A1
Sacchi, A1
Santos, M1
Theobald, A1
Vagenende, B1
Verani, A1
Du, L1
Liu, X1
Ren, Y1
Li, J9
Li, P1
Jiao, Q1
Meng, P1
Wang, F2
Wang, YS1
Wang, C3
Zhou, X2
Wang, W1
Wang, S2
Hou, J1
Zhang, A1
Lv, B1
Gao, C1
Pang, D1
Lu, K1
Ahmad, NH1
Wang, L2
Zhu, J2
Zhang, L3
Zhuang, T1
Tu, J1
Zhao, Z1
Qu, Y1
Yao, H1
Wang, X6
Lee, DF1
Shen, J3
Wen, L1
Huang, G2
Xie, X1
Zhao, Q1
Hu, W1
Zhang, Y4
Wu, X1
Lu, J2
Li, M1
Li, W3
Wu, W1
Du, F1
Ji, H1
Yang, X2
Xu, Z1
Wan, L1
Wen, Q1
Cho, CH1
Zou, C1
Xiao, Z1
Liao, J1
Su, X1
Bi, Z1
Su, Q1
Huang, H1
Wei, Y2
Gao, Y3
Na, KJ1
Choi, H1
Oh, HR1
Kim, YH1
Lee, SB1
Jung, YJ1
Koh, J1
Park, S1
Lee, HJ1
Jeon, YK1
Chung, DH1
Paeng, JC1
Park, IK1
Kang, CH1
Cheon, GJ1
Kang, KW1
Lee, DS1
Kim, YT1
Pajuelo-Lozano, N1
Alcalá, S1
Sainz, B1
Perona, R1
Sanchez-Perez, I1
Logotheti, S1
Marquardt, S1
Gupta, SK1
Richter, C1
Edelhäuser, BAH1
Engelmann, D1
Brenmoehl, J1
Söhnchen, C1
Murr, N1
Alpers, M1
Singh, KP1
Wolkenhauer, O1
Heckl, D1
Spitschak, A1
Pützer, BM1
Liao, Y1
Cheng, J1
Kong, X1
Li, S1
Zhang, M4
Zhang, H1
Yang, T2
Dong, Y1
Xu, Y1
Yuan, Z1
Cao, J1
Zheng, Y1
Luo, Z1
Mei, Z1
Yao, Y1
Liu, Z2
Liang, C1
Yang, H2
Song, Y1
Yu, K1
Zhu, C1
Huang, Z1
Qian, J1
Ge, J1
Hu, J2
Wang, H3
Liu, Y5
Mi, Y1
Kong, H1
Xi, D1
Yan, W2
Luo, X1
Ning, Q1
Chang, X2
Zhang, T2
Wang, Q2
Rathore, MG1
Reddy, K1
Chen, H1
Shin, SH1
Ma, WY1
Bode, AM1
Dong, Z1
Mu, W1
Liu, C4
Gao, F1
Qi, Y1
Lu, H1
Zhang, X5
Cai, X1
Ji, RY1
Hou, Y3
Tian, J2
Shi, Y1
Ying, S1
Tan, M1
Feng, G1
Kuang, Y1
Chen, D1
Wu, D3
Zhu, ZQ1
Tang, HX1
Shi, ZE1
Kang, J1
Liu, Q2
Qi, J2
Mu, J1
Cong, Z1
Chen, S2
Fu, D1
Celestrin, CP1
Rocha, GZ1
Stein, AM1
Guadagnini, D1
Tadelle, RM1
Saad, MJA1
Oliveira, AG1
Bianconi, V1
Bronzo, P1
Banach, M1
Sahebkar, A1
Mannarino, MR1
Pirro, M1
Patsourakos, NG1
Kouvari, M1
Kotidis, A1
Kalantzi, KI1
Tsoumani, ME1
Anastasiadis, F1
Andronikos, P1
Aslanidou, T1
Efraimidis, P1
Georgiopoulos, A1
Gerakiou, K1
Grigoriadou-Skouta, E1
Grigoropoulos, P1
Hatzopoulos, D1
Kartalis, A1
Lyras, A1
Markatos, G1
Mikrogeorgiou, A1
Myroforou, I1
Orkopoulos, A1
Pavlidis, P1
Petras, C1
Riga, M1
Skouloudi, M1
Smyrnioudis, N1
Thomaidis, K1
Tsikouri, GE1
Tsikouris, EI1
Zisimos, K1
Vavoulis, P1
Vitali, MG1
Vitsas, G1
Vogiatzidis, C1
Chantanis, S1
Fousas, S1
Panagiotakos, DB1
Tselepis, AD1
Jungen, C1
Alken, FA1
Eickholt, C1
Scherschel, K1
Kuklik, P1
Klatt, N1
Schwarzl, J1
Moser, J1
Jularic, M1
Akbulak, RO1
Schaeffer, B1
Willems, S1
Meyer, C1
Nowak, JK1
Szczepanik, M1
Trypuć, M1
Pogorzelski, A1
Bobkowski, W1
Grytczuk, M1
Minarowska, A1
Wójciak, R1
Walkowiak, J1
Lu, Y2
Xi, J1
Li, C1
Hu, X1
Zhang, F1
Wei, H1
Wang, Z1
Gurzu, S1
Jung, I1
Sugimura, H2
Stefan-van Staden, RI1
Yamada, H1
Natsume, H1
Iwashita, Y1
Szodorai, R1
Szederjesi, J1
Yari, D1
Ehsanbakhsh, Z1
Validad, MH1
Langroudi, FH1
Esfandiari, H1
Prager, A1
Hassanpour, K1
Kurup, SP1
Mets-Halgrimson, R1
Yoon, H1
Zeid, JL1
Mets, MB1
Rahmani, B1
Araujo-Castillo, RV1
Culquichicón, C1
Solis Condor, R1
Efendi, F1
Sebayang, SK1
Astutik, E1
Hadisuyatmana, S1
Has, EMM1
Kuswanto, H1
Foroutan, T1
Ahmadi, F1
Moayer, F1
Khalvati, S1
Zhang, Q2
Lyu, Y1
Huang, J2
Yu, N1
Wen, Z1
Hou, H1
Zhao, T1
Gupta, A1
Khosla, N1
Govindasamy, V1
Saini, A1
Annapurna, K1
Dhakate, SR1
Akkaya, Ö1
Chandgude, AL1
Dömling, A1
Harnett, J1
Oakes, K1
Carè, J1
Leach, M1
Brown, D1
Cramer, H1
Pinder, TA1
Steel, A1
Anheyer, D1
Cantu, J1
Valle, J1
Flores, K1
Gonzalez, D1
Valdes, C1
Lopez, J1
Padilla, V1
Alcoutlabi, M1
Parsons, J1
Núñez, K1
Hamed, M1
Fort, D1
Bruce, D1
Thevenot, P1
Cohen, A1
Weber, P1
Menezes, AMB1
Gonçalves, H1
Perez-Padilla, R1
Jarvis, D1
de Oliveira, PD1
Wehrmeister, FC1
Mir, S1
Wong, J1
Ryan, CM1
Bellingham, G1
Singh, M2
Waseem, R1
Eckert, DJ1
Chung, F1
Hegde, H1
Shimpi, N1
Panny, A1
Glurich, I1
Christie, P1
Acharya, A1
English, KL1
Downs, M1
Goetchius, E1
Buxton, R1
Ryder, JW1
Ploutz-Snyder, R1
Guilliams, M1
Scott, JM1
Ploutz-Snyder, LL1
Martens, C1
Goplen, FK1
Aasen, T1
Gjestad, R1
Nordfalk, KF1
Nordahl, SHG1
Inoue, T1
Soshi, S1
Kubota, M1
Marumo, K1
Mortensen, NP1
Caffaro, MM1
Patel, PR2
Uddin, MJ1
Aravamudhan, S1
Sumner, SJ1
Fennell, TR1
Gal, RL1
Cohen, NJ1
Kruger, D1
Beck, RW1
Bergenstal, RM1
Calhoun, P1
Cushman, T1
Haban, A1
Hood, K1
Johnson, ML1
McArthur, T1
Olson, BA1
Weinstock, RS1
Oser, SM1
Oser, TK1
Bugielski, B1
Strayer, H1
Aleppo, G1
Maruyama, H1
Hirayama, K1
Yamashita, M1
Ohgi, K1
Tsujimoto, R1
Takayasu, M1
Shimohata, H1
Kobayashi, M1
Buscagan, TM1
Rees, DC1
Jaborek, JR1
Zerby, HN1
Wick, MP1
Fluharty, FL1
Moeller, SJ1
Razavi, P1
Dickler, MN1
Shah, PD1
Toy, W1
Brown, DN1
Won, HH1
Li, BT1
Shen, R1
Vasan, N1
Modi, S1
Jhaveri, K1
Caravella, BA1
Patil, S1
Selenica, P1
Zamora, S1
Cowan, AM1
Comen, E1
Singh, A1
Covey, A1
Berger, MF1
Hudis, CA1
Norton, L1
Nagy, RJ1
Odegaard, JI1
Lanman, RB1
Solit, DB1
Robson, ME1
Lacouture, ME1
Brogi, E1
Reis-Filho, JS1
Moynahan, ME1
Scaltriti, M1
Chandarlapaty, S1
Papouskova, K1
Moravcova, M1
Masrati, G1
Ben-Tal, N1
Sychrova, H1
Zimmermannova, O1
Fang, J1
Fan, Y1
Luo, T2
Su, H1
Tsetseris, L1
Anthopoulos, TD1
Liu, SF1
Zhao, K1
Sacan, O1
Turkyilmaz, IB1
Bayrak, BB1
Mutlu, O1
Akev, N1
Yanardag, R1
Gruber, S1
Kamnoedboon, P1
Özcan, M1
Srinivasan, M1
Jo, YH1
Oh, HK1
Jeong, SY1
Lee, BG1
Zheng, J1
Guan, H1
Li, D2
Tan, H1
Maji, TK1
J R, A1
Mukherjee, S1
Alexander, R1
Mondal, A1
Das, S1
Sharma, RK1
Chakraborty, NK1
Dasgupta, K1
Sharma, AMR1
Hawaldar, R1
Pandey, M1
Naik, A1
Majumdar, K1
Pal, SK1
Adarsh, KV1
Ray, SK1
Karmakar, D1
Ma, Y2
Gao, W1
Ma, S1
Lin, W1
Zhou, T1
Wu, T1
Wu, Q1
Ye, C1
He, X1
Jiang, F1
Yuan, D1
Chen, Q1
Hong, M1
Chen, K1
Hussain, M1
Razi, SS1
Yildiz, EA1
Zhao, J2
Yaglioglu, HG1
Donato, MD1
Jiang, J1
Jamil, MI1
Zhan, X1
Chen, F1
Cheng, D1
Wu, CT1
Utsunomiya, T1
Ichii, T1
Fujinami, S1
Nakajima, K1
Sanchez, DM1
Raucci, U1
Ferreras, KN1
Martínez, TJ1
Mordi, NA1
Mordi, IR1
Singh, JS1
McCrimmon, RJ1
Struthers, AD1
Lang, CC1
Wang, XW1
Yuan, LJ1
Yang, Y1
Chen, WF1
Luo, R1
Yang, K1
Amarasiri, SS1
Attanayake, AP1
Arawwawala, LDAM1
Jayatilaka, KAPW1
Mudduwa, LKB1
Ogunsuyi, O2
Akanni, O1
Alabi, O1
Alimba, C1
Adaramoye, O1
Cambier, S1
Eswara, S1
Gutleb, AC1
Bakare, A1
Gu, Z1
Cong, J1
Pellegrini, M1
Palmieri, S1
Ricci, A1
Serio, A1
Paparella, A1
Lo Sterzo, C1
Jadeja, SD1
Vaishnav, J1
Mansuri, MS1
Shah, C1
Mayatra, JM1
Shah, A1
Begum, R1
Song, H2
Lian, Y1
Wan, T1
Schultz-Lebahn, A1
Skipper, MT1
Hvas, AM1
Larsen, OH1
Hijazi, Z1
Granger, CB1
Hohnloser, SH1
Westerbergh, J1
Lindbäck, J1
Alexander, JH1
Keltai, M1
Parkhomenko, A1
López-Sendón, JL1
Lopes, RD1
Siegbahn, A1
Wallentin, L1
El-Tarabany, MS1
Saleh, AA1
El-Araby, IE1
El-Magd, MA1
van Ginkel, MPH1
Schijven, MP1
van Grevenstein, WMU1
Schreuder, HWR1
Pereira, EDM1
da Silva, J1
Carvalho, PDS1
Grivicich, I1
Picada, JN1
Salgado Júnior, IB1
Vasques, GJ1
Pereira, MADS1
Reginatto, FH1
Ferraz, ABF1
Vasilenko, EA1
Gorshkova, EN1
Astrakhantseva, IV1
Drutskaya, MS1
Tillib, SV1
Nedospasov, SA1
Mokhonov, VV1
Nam, YW1
Cui, M1
Orfali, R1
Viegas, A1
Nguyen, M1
Mohammed, EHM1
Zoghebi, KA1
Rahighi, S1
Parang, K1
Patterson, KC1
Kahanovitch, U1
Gonçalves, CM1
Hablitz, JJ1
Staruschenko, A1
Mulkey, DK1
Olsen, ML1
Gu, L1
Cao, X1
Mukhtar, A1
Zhang, YY1
Zhu, Y1
Lu, DZ1
Dong, W1
Bi, WJ1
Feng, XJ1
Wen, LM1
Sun, H1
Qi, MC1
Chang, CC1
Dinh, TK1
Lee, YA1
Wang, FN1
Sung, YC1
Yu, PL1
Chiu, SC1
Shih, YC1
Wu, CY1
Huang, YD1
Lu, TT1
Wan, D1
Sakizadeh, J1
Cline, JP1
Snyder, MA1
Kiely, CJ1
McIntosh, S1
Jiang, X1
Cao, JW1
Zhao, CK1
Yang, R1
Zhang, QY1
Chen, KJ2
Liu, H1
He, Z1
Chen, B1
Wu, J1
Du, X1
Moore, J1
Blank, BR1
Eksterowicz, J1
Sutimantanapi, D1
Yuen, N1
Metzger, T1
Chan, B1
Huang, T1
Chen, X1
Duong, F1
Kong, W1
Chang, JH1
Sun, J1
Zavorotinskaya, T1
Ye, Q1
Junttila, MR1
Ndubaku, C1
Friedman, LS1
Fantin, VR1
Sun, D1
Fei, P1
Xie, Q1
Jiang, Y1
Feng, H1
Chang, Y1
Kang, H1
Xing, M1
Chen, J2
Shao, Z1
Yuan, C1
Wu, Y1
Allan, R1
Canham, K1
Wallace, R1
Singh, D1
Ward, J1
Cooper, A1
Newcomb, C1
Nammour, S1
El Mobadder, M1
Maalouf, E1
Namour, M1
Namour, A1
Rey, G1
Matamba, P1
Matys, J1
Zeinoun, T1
Grzech-Leśniak, K1
Segabinazi Peserico, C1
Garozi, L1
Zagatto, AM1
Machado, FA1
Hirth, JM1
Dinehart, EE1
Lin, YL1
Kuo, YF1
Nouri, SS1
Ritchie, C1
Volow, A1
Li, B2
McSpadden, S1
Dearman, K1
Kotwal, A1
Sudore, RL1
Ward, L1
Thakur, A1
Kondadasula, SV1
Ji, K1
Schalk, DL1
Bliemeister, E1
Ung, J1
Aboukameel, A1
Casarez, E1
Sloane, BF1
Lum, LG1
Xiao, M1
Feng, X1
Gao, R1
Du, B1
Brooks, T1
Zwirner, J1
Hammer, N1
Ondruschka, B1
Jermy, M1
Luengo, A1
Marzo, I1
Reback, M1
Daubit, IM1
Fernández-Moreira, V1
Metzler-Nolte, N1
Gimeno, MC1
Tonchev, I1
Heberman, D1
Peretz, A1
Medvedovsky, AT1
Gotsman, I1
Rashi, Y1
Poles, L1
Goland, S1
Perlman, GY1
Danenberg, HD1
Beeri, R1
Shuvy, M1
Fu, Q1
Yang, D1
Sarapulova, A1
Pang, Q1
Meng, Y1
Wei, L1
Ehrenberg, H1
Kim, CC1
Jeong, SH1
Oh, KH1
Nam, KT1
Sun, JY1
Ning, J1
Duan, Z1
Kershaw, SV1
Rogach, AL1
Gao, Z1
Wang, T1
Cao, T1
Guo, L1
Fu, Y1
Seeger, ZL1
Izgorodina, EI1
Hue, S1
Beldi-Ferchiou, A1
Bendib, I1
Surenaud, M1
Fourati, S1
Frapard, T1
Rivoal, S1
Razazi, K1
Carteaux, G1
Delfau-Larue, MH1
Mekontso-Dessap, A1
Audureau, E1
de Prost, N1
Gao, SS1
Duangthip, D1
Lo, ECM1
Chu, CH1
Roberts, W1
Rosenheck, RA1
Miyake, T1
Kimoto, E1
Luo, L1
Mathialagan, S1
Horlbogen, LM1
Ramanathan, R1
Wood, LS1
Johnson, JG1
Le, VH1
Vourvahis, M1
Rodrigues, AD1
Muto, C1
Furihata, K1
Sugiyama, Y1
Kusuhara, H1
Gong, Q1
Song, W2
Sun, B1
Cao, P1
Gu, S1
Sun, X1
Zhou, G1
Toma, C1
Khandhar, S1
Zalewski, AM1
D'Auria, SJ1
Tu, TM1
Jaber, WA1
Cho, J2
Suwandaratne, NS1
Razek, S1
Choi, YH1
Piper, LFJ1
Watson, DF1
Banerjee, S1
Xie, S1
Lindsay, AP1
Bates, FS1
Lodge, TP1
Hao, Y1
Chapovetsky, A1
Liu, JJ1
Welborn, M1
Luna, JM1
Do, T1
Haiges, R1
Miller Iii, TF1
Marinescu, SC1
Lopez, SA1
Compter, I1
Eekers, DBP1
Hoeben, A1
Rouschop, KMA1
Reymen, B1
Ackermans, L1
Beckervordersantforth, J1
Bauer, NJC1
Anten, MM1
Wesseling, P1
Postma, AA1
De Ruysscher, D1
Lambin, P1
Qiang, L1
Yang, S1
Cui, YH1
He, YY1
Kumar, SK1
Jacobus, SJ1
Cohen, AD1
Weiss, M1
Callander, N1
Singh, AK1
Parker, TL1
Menter, A1
Parsons, B1
Kumar, P1
Kapoor, P1
Rosenberg, A1
Zonder, JA1
Faber, E1
Lonial, S1
Anderson, KC1
Richardson, PG1
Orlowski, RZ1
Wagner, LI1
Rajkumar, SV1
Li, G1
Hou, G1
Cui, J1
Xie, H1
Sun, Z1
Fang, Z1
Dunstand-Guzmán, E1
Hallal-Calleros, C1
Hernández-Velázquez, VM1
Canales-Vargas, EJ1
Domínguez-Roldan, R1
Pedernera, M1
Peña-Chora, G1
Flores-Pérez, I1
Kim, MJ1
Han, C1
White, K1
Park, HJ1
Ding, D1
Boyd, K1
Rothenberger, C1
Bose, U1
Carmichael, P1
Linser, PJ1
Tanokura, M1
Salvi, R1
Someya, S1
Samuni, A1
Goldstein, S1
Divya, KP1
Dharuman, V1
Feng, J2
Qian, Y1
Cheng, Q1
Ma, H1
Ren, X1
Wei, Q1
Pan, W1
Guo, J1
Situ, B1
An, T1
Zheng, L1
Augusto, S1
Ratola, N1
Tarín-Carrasco, P1
Jiménez-Guerrero, P1
Turco, M1
Schuhmacher, M1
Costa, S1
Teixeira, JP1
Costa, C1
Syed, A1
Marraiki, N1
Al-Rashed, S1
Elgorban, AM1
Yassin, MT1
Chankhanittha, T1
Nanan, S1
Sorokina, KN1
Samoylova, YV1
Gromov, NV1
Ogorodnikova, OL1
Parmon, VN1
Ye, J1
Liao, W1
Zhang, P1
Nabi, M1
Cai, Y1
Alsbou, EM1
Omari, KW1
Adeosun, WA1
Asiri, AM1
Marwani, HM1
Barral, M1
Jemal-Turki, A1
Beuvon, F1
Soyer, P1
Camparo, P1
Cornud, F1
Atwater, BD1
Jones, WS1
Loring, Z1
Friedman, DJ1
Namburath, M1
Papirio, S1
Moscariello, C1
Di Costanzo, N1
Pirozzi, F1
Alappat, BJ1
Sreekrishnan, TR1
Volpin, F1
Woo, YC1
Kim, H1
Freguia, S1
Jeong, N1
Choi, JS1
Phuntsho, S1
Shon, HK1
Domínguez-Zambrano, E1
Pedraza-Chaverri, J1
López-Santos, AL1
Medina-Campos, ON1
Cruz-Rivera, C1
Bueno-Hernández, F1
Espinosa-Cuevas, A1
Bulavaitė, A1
Dalgediene, I1
Michailoviene, V1
Pleckaityte, M1
Sauerbier, P1
Köhler, R1
Renner, G1
Militz, H1
Park, TH1
Bae, SH1
Bong, SM1
Ryu, SE1
Jang, H1
Lee, BI1
Bajbouj, K1
Ramakrishnan, RK1
Saber-Ayad, M1
Omar, HA1
Saheb Sharif-Askari, N1
Shafarin, J1
Elmoselhi, AB1
Ihmaid, A1
AlHaj Ali, S1
Alalool, A1
Abdullah, R1
Hamid, Q1
Çeliktas, M1
Tanaka, I1
Tripathi, SC1
Fahrmann, JF1
Aguilar-Bonavides, C1
Villalobos, P1
Delgado, O1
Dhillon, D1
Dennison, JB1
Ostrin, EJ1
Behrens, C1
Do, KA1
Gazdar, AF1
Hanash, SM1
Taguchi, A1
Lu, W1
Cheng, F1
Yao, X1
Liu, M1
Shen, X1
Jiang, H1
Fábián, K1
Puskás, R1
Kakuk, T1
Prés, L1
Fejes, D1
Szegedi, Z1
Rojkó, L1
Szállási, Z1
Döme, B1
Pipek, O1
Moldvay, J1
Liu, F1
Gao, P1
Quinn, MM1
Merlino, AA1
Benes, C1
Gray, NS1
Wong, KK1
Xing, J1
Hammill, JT1
Bhasin, D1
Scott, DC1
Min, J1
Yang, L1
Kim, HS1
Connelly, MC1
Hammill, C1
Holbrook, G1
Jeffries, C1
Singh, B1
Schulman, BA1
Guy, RK1
Wang, JN1
Zhang, ZR1
Che, Y1
Yuan, ZY1
Lu, ZL1
Li, N1
Wan, J1
Sun, HD1
Sun, N1
Puno, PT1
He, J1
Pham-Danis, C1
Gehrke, S1
Danis, E1
Rozhok, AI1
Daniels, MW1
Gao, D1
Collins, C1
Paola, JTD1
D'Alessandro, A1
DeGregori, J1
Sakamoto, A1
Yagi, K1
Okamura, T1
Harada, T1
Usuda, J1
Cai, L1
Guo, Y1
Xie, M1
Tian, H1
Li, A1
Miao, Y1
Zhang, TJ1
Kamara, MO1
Lu, GQ1
Xu, HL1
Wang, DP1
Meng, FH1
Grabauskiene, S1
Bergeron, EJ1
Thomas, DG1
Giordano, TJ1
Beer, DG1
Morgan, MA1
Reddy, RM1
Mak, JP1
Man, WY1
Ma, HT1
Poon, RY1
Krishnamurthy, S1
Ng, VW1
Gao, S1
Tan, MH1
Hedrick, JL1
Yang, YY1
Bazin, MA1
Rousseau, B1
Marhadour, S1
Tomasoni, C1
Evenou, P1
Piessard, S1
Vaisberg, AJ1
Ruchaud, S1
Bach, S1
Roussakis, C1
Marchand, P1
Park, JS1
Lee, C1
Kim, HK1
Kim, D1
Son, JB1
Ko, E1
Cho, JH1
Kim, ND1
Nan, HY1
Kim, CY1
Yoon, S1
Lee, SH1
Choi, HG1
Smida, M1
Fece de la Cruz, F1
Kerzendorfer, C1
Uras, IZ1
Mair, B1
Mazouzi, A1
Suchankova, T1
Konopka, T1
Katz, AM1
Paz, K1
Nagy-Bojarszky, K1
Muellner, MK1
Bago-Horvath, Z1
Haura, EB1
Loizou, JI1
Nijman, SM1
Li, L1
Winter, MC1
Potter, VA1
Woll, PJ1
McMorris, TC1
Chimmani, R1
Alisala, K1
Staake, MD1
Banda, G1
Kelner, MJ1
Quan, Z1
Purser, C1
Baker, RC1
Dwyer, T1
Bhagat, R1
Sheng, Y1
Leszczynski, JR1
Schmidt, J1
Garambois, V1
Rocheblave, L1
Martinez, J1
Pèlegrin, A1
Cavelier, F1
Vivès, E1
Yoon, SJ1
Jin, J1
Choi, SH1
Seol, HJ1
Lee, JI1
Nam, DH1
Yoo, HY1
Yamamoto, K1
Maeda, H1
Takeuchi, Y1
Funakoshi, Y1
Maekura, R1
Okumura, M1
Lim, S1
Ryu, JH1
Im, C1
Yim, CB1
GOLDBERG, MF1
TASHJIAN, AH1
ORDER, SE1
DAMMIN, GJ1
BICKERS, JN1
Sakai, H1
Igarashi, K1
Imai, M1
Miura, K1
Kanai, M1
Okazaki, A1
Hess, SM1
Mounce, AM1
Sequeira, RC1
Augustus, TM1
Ackley, MC1
Bierbach, U1
Cohen, RB1
Langer, CJ1
Simon, GR1
Eisenberg, PD1
Hainsworth, JD1
Madajewicz, S1
Cosgriff, TM1
Pierce, K1
Xu, H1
Liau, K1
Healey, D1
Khan, N1
Afaq, F1
Kweon, MH1
Kim, K1
Mukhtar, H1
Herzog, A1
Nelson, HG1
Shelton, FJ1
Wetzel, WH1
Tanaka, T1
Fujii, M1
Nishikawa, A1
Bunai, Y1
Obayashi, F1
Sugie, S1
Shima, H1
Yoshimi, N1
Kuniyashu, T1
Kato, K1
Fujii, K1
Nomoto, K1
Gibney, E1
Elia, M1
Jebb, SA1
Murgatroyd, P1
Jennings, G1
Mirvish, SS3
Cardesa, A1
Wallcave, L1
Shubik, P1
Narisawa, T1
Wong, CQ1
Maronpot, RR1
Weisburger, JH1
Lee, CS1
Gibson, NW1
Dick, TT1
Webb, TA1
Dunn, B1
Mendelson, E1
Soares, N1
Bustin, M1
Druckrey, H1
Ivankovic, S1
Bücheler, J1
Preussmann, R1
Thomas, C1
Casey, TP1
Frei, JV3
Terracini, B1
Testa, MC1
Rudali, G1
Cohen, SM1
Greenspan, EM1
Weiner, MJ1
Kabakow, B1
Rothbard, S1
Watson, RF1
Kang, KY1
Higashino, K1
Hashinotsume, M1
Takahashi, Y1
Aoki, T1
Baylet, R1
Diebolt, G1
Grappin, G1
Diop, S1
de Medeiros, D1
LePar, E1
Faust, DS1
Brady, LW1
Beckloff, GL1
Greenblatt, M1
Kommineni, VR1
Mayo, JG1
Laster, WR1
Andrews, CM1
Schabel, FM1
Johnston, TP1
Kolesnichenko, TS2
Matsuyama, M1
Suzuki, H1
Korman, NP1
Vermel', EM1
Milonov, BV1
Orlova, RS1
Fishman, WH1
Fennelly, JJ1
Dunne, J1
McGeeney, K1
Chong, L1
FitzGerald, M1
Laursen, B1
Gormsen, J1
Shabad, LM1
Moon, JH1
Kelly, MG1
O'Gara, RW1
Yancey, ST1
Botkin, C1
Malyshev, IuI1
Dement'eva, AM1
Karpova, EP1
Kaninina, TA1
Kondranin, GV1
Polianskii, GN1
Herrold, KM1

Reviews

2 reviews available for urea and Lung Neoplasms

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Blocking the formation of N-nitroso compounds with ascorbic acid in vitro and in vivo.
    Annals of the New York Academy of Sciences, 1975, Sep-30, Volume: 258

    Topics: Adenoma; Amines; Aminopyrine; Animals; Ascorbic Acid; Dimethylnitrosamine; Female; Liver; Lung Neopl

1975

Trials

5 trials available for urea and Lung Neoplasms

ArticleYear
Landiolol, an ultra-short acting beta-1 blocker, for preventing postoperative lung cancer recurrence: study protocol for a phase III, multicenter randomized trial with two parallel groups of patients.
    Trials, 2019, Dec-11, Volume: 20, Issue:1

    Topics: Adrenergic beta-1 Receptor Antagonists; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic;

2019
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Perioperative Administration of an Intravenous Beta-Blocker Landiolol Hydrochloride in Patients with Lung Cancer: A Japanese Retrospective Exploratory Clinical Study.
    Scientific reports, 2019, 03-26, Volume: 9, Issue:1

    Topics: Administration, Intravenous; Adrenergic beta-Antagonists; Aged; Disease-Free Survival; Female; Human

2019
A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC).
    Cancer chemotherapy and pharmacology, 2007, Volume: 60, Issue:1

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve;

2007
Triple combination chemotherapy of disseminated melanoma.
    Cancer, 1972, Volume: 29, Issue:6

    Topics: Aged; Alkylating Agents; Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Drug Combinati

1972

Other Studies

72 other studies available for urea and Lung Neoplasms

ArticleYear
Discovery of 3,5-diaryl-1H-pyrazol-based ureas as potent RET inhibitors.
    European journal of medicinal chemistry, 2023, May-05, Volume: 251

    Topics: Antineoplastic Agents; Humans; Lung Neoplasms; Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene

2023
Triple targeting of mutant EGFR
    Journal of enzyme inhibition and medicinal chemistry, 2023, Volume: 38, Issue:1

    Topics: Anti-Inflammatory Agents; Celecoxib; Cyclooxygenase 2; Diclofenac; ErbB Receptors; Humans; Lung Neop

2023
Antiproliferative evaluation of various aminoquinoline derivatives.
    Acta pharmaceutica (Zagreb, Croatia), 2019, Dec-01, Volume: 69, Issue:4

    Topics: Aminoquinolines; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Colo

2019
Prostate Cancer Lymphangitic Pulmonary Carcinomatosis: Appearance on 18F-FDG PET/CT and 18F-DCFPyL PET/CT.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:9

    Topics: Disease Progression; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lysine; Male; Middle Aged; Posi

2020
Radiosensitization of NSCLC cells to X-rays and carbon ions by the CHK1/CHK2 inhibitor AZD7762, Honokiol and Tunicamycin.
    Radiation and environmental biophysics, 2020, Volume: 59, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Carbon; Carcinoma, Non-Small-Cell Lung; Cell L

2020
Crystal Structure of the Kinase Domain of MerTK in Complex with AZD7762 Provides Clues for Structure-Based Drug Development.
    International journal of molecular sciences, 2020, Oct-23, Volume: 21, Issue:21

    Topics: A549 Cells; c-Mer Tyrosine Kinase; Cell Line, Tumor; Crystallography, X-Ray; Down-Regulation; Drug S

2020
PRMT5 Selective Inhibitor Enhances Therapeutic Efficacy of Cisplatin in Lung Cancer Cells.
    International journal of molecular sciences, 2021, Jun-07, Volume: 22, Issue:11

    Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Proliferation; Cisplatin; Drug Synergism; Enzyme

2021
Role of CPS1 in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated Lung Adenocarcinoma.
    Journal of the National Cancer Institute, 2017, 03-01, Volume: 109, Issue:3

    Topics: Adenocarcinoma; Aged; AMP-Activated Protein Kinase Kinases; Carbamoyl-Phosphate Synthase (Ammonia);

2017
Selective targeting p53
    Oncogene, 2017, 08-17, Volume: 36, Issue:33

    Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Cell Cy

2017
Renal Impairment Hampers Bisphosphonate Treatment in a Quarter of Lung Cancer Patients with Bone Metastasis.
    Basic & clinical pharmacology & toxicology, 2018, Volume: 122, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Neoplasms; Comorbidity; Creat

2018
Gemcitabine and Chk1 Inhibitor AZD7762 Synergistically Suppress the Growth of Lkb1-Deficient Lung Adenocarcinoma.
    Cancer research, 2017, 09-15, Volume: 77, Issue:18

    Topics: Adenocarcinoma; AMP-Activated Protein Kinase Kinases; Animals; Antimetabolites, Antineoplastic; Apop

2017
UNBS5162 inhibits the proliferation of human A549 non-small-cell lung cancer cells by promoting apoptosis.
    Thoracic cancer, 2018, Volume: 9, Issue:1

    Topics: A549 Cells; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Humans; Lung Neoplasms; N

2018
Discovery of an Orally Bioavailable Inhibitor of Defective in Cullin Neddylation 1 (DCN1)-Mediated Cullin Neddylation.
    Journal of medicinal chemistry, 2018, 04-12, Volume: 61, Issue:7

    Topics: Animals; Antineoplastic Agents; Biological Availability; Carcinoma, Squamous Cell; Cell Line, Tumor;

2018
Acetyl-macrocalin B, an ent-kaurane diterpenoid, initiates apoptosis through the ROS-p38-caspase 9-dependent pathway and induces G2/M phase arrest via the Chk1/2-Cdc25C-Cdc2/cyclin B axis in non-small cell lung cancer.
    Cancer biology & therapy, 2018, 07-03, Volume: 19, Issue:7

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Non-Small-Cell Lung;

2018
Urea Cycle Sustains Cellular Energetics upon EGFR Inhibition in EGFR-Mutant NSCLC.
    Molecular cancer research : MCR, 2019, Volume: 17, Issue:6

    Topics: Carbamoyl-Phosphate Synthase (Ammonia); Carcinoma, Non-Small-Cell Lung; Cell Line; Cell Line, Tumor;

2019
Fbxo6 confers drug-sensitization to cisplatin via inhibiting the activation of Chk1 in non-small cell lung cancer.
    FEBS letters, 2019, Volume: 593, Issue:14

    Topics: A549 Cells; Aged; Aged, 80 and over; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Proliferation;

2019
Discovery of N-phenyl-(2,4-dihydroxypyrimidine-5-sulfonamido) phenylurea-based thymidylate synthase (TS) inhibitor as a novel multi-effects antitumor drugs with minimal toxicity.
    Cell death & disease, 2019, 07-11, Volume: 10, Issue:7

    Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Mo

2019
Checkpoint kinase 1 protein expression indicates sensitization to therapy by checkpoint kinase 1 inhibition in non-small cell lung cancer.
    The Journal of surgical research, 2014, Volume: 187, Issue:1

    Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Car

2014
Pharmacological targeting the ATR-CHK1-WEE1 axis involves balancing cell growth stimulation and apoptosis.
    Oncotarget, 2014, Nov-15, Volume: 5, Issue:21

    Topics: Apoptosis; Ataxia Telangiectasia Mutated Proteins; Blotting, Western; Carcinoma, Non-Small-Cell Lung

2014
Codelivery of dual drugs from polymeric micelles for simultaneous targeting of both cancer cells and cancer stem cells.
    Nanomedicine (London, England), 2015, Volume: 10, Issue:18

    Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Line,

2015
Discovery of Novel (Imidazo[1,2-a]pyrazin-6-yl)ureas as Antiproliferative Agents Targeting P53 in Non-small Cell Lung Cancer Cell Lines.
    Anticancer research, 2016, Volume: 36, Issue:4

    Topics: Animals; Antineoplastic Agents; BALB 3T3 Cells; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Ce

2016
Suppression of the metastatic spread of breast cancer by DN10764 (AZD7762)-mediated inhibition of AXL signaling.
    Oncotarget, 2016, Dec-13, Volume: 7, Issue:50

    Topics: A549 Cells; Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Axl Receptor Tyrosine Kinase;

2016
MEK inhibitors block growth of lung tumours with mutations in ataxia-telangiectasia mutated.
    Nature communications, 2016, 12-06, Volume: 7

    Topics: Animals; Ataxia Telangiectasia Mutated Proteins; Benzamides; Cell Line, Tumor; Cell Proliferation; D

2016
[Relationships between Serum Albumin and Urea Level and the Clinical Pathological Characteristics and Survival Time in Patients with Lung Cancer].
    Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2017, Mar-20, Volume: 20, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging;

2017
Raised serum urea predicts for early death in small cell lung cancer.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2008, Volume: 20, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; C

2008
Structure-activity studies of urea, carbamate, and sulfonamide derivatives of acylfulvene.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Adenocarcinoma; Animals; B-Lymphocytes; Carbamates; Cell Line; Cell Survival; Dose-Response Relation

2010
Determination of derivatized urea in exhaled breath condensate by LC-MS.
    Journal of chromatographic science, 2010, Volume: 48, Issue:2

    Topics: Breath Tests; Calibration; Chromatography, High Pressure Liquid; Exhalation; Humans; Lung Neoplasms;

2010
Cyclization of peptides through a urea bond: application to the Arg-Gly-Asp tripeptide.
    Chembiochem : a European journal of chemical biology, 2010, May-17, Volume: 11, Issue:8

    Topics: Angiogenesis Inhibitors; Animals; Cell Line; Cell Line, Tumor; Cyclization; Humans; Integrin alphaVb

2010
Inhibition of checkpoint kinase 1 sensitizes lung cancer brain metastases to radiotherapy.
    Biochemical and biophysical research communications, 2011, Mar-04, Volume: 406, Issue:1

    Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Checkpoint Kinase 1; Gene Deletion; Humans; Lung Neoplas

2011
Efficacy of low-dose landiolol, an ultrashort-acting β-blocker, on postoperative atrial fibrillation in patients undergoing pulmonary resection for lung cancer.
    General thoracic and cardiovascular surgery, 2011, Volume: 59, Issue:12

    Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Female; Hemodynamics; Humans; Infusions, Int

2011
Synthesis and cytotoxicity of new 3-alkyl-1-(1-methyl-2-phenylethyl)ureas related to ceramide.
    Archives of pharmacal research, 2003, Volume: 26, Issue:4

    Topics: Ceramides; Colonic Neoplasms; Drug Screening Assays, Antitumor; Humans; In Vitro Techniques; Kidney

2003
RENAL ADENOCARCINOMA CONTAINING A PARATHYROID HORMONE-LIKE SUBSTANCE AND ASSOCIATED WITH MARKED HYPERCALCEMIA.
    The American journal of medicine, 1964, Volume: 36

    Topics: Adenocarcinoma; Alkaline Phosphatase; Antigens; Blood Chemical Analysis; Bone Neoplasms; Calcium; Ca

1964
PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CARCINOMA OF THE LUNG.
    Cancer chemotherapy reports, 1964, Volume: 40

    Topics: Adult; Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Drug Therapy; Humans; Hydroxyurea

1964
[Perioperative heart rate control with landiolol for a patient with rapid atrial fibrillation complicated with low cardiac function].
    Masui. The Japanese journal of anesthesiology, 2004, Volume: 53, Issue:5

    Topics: Anesthesia, Epidural; Anesthesia, General; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardi

2004
Platinum-acridinylthiourea conjugates show cell line-specific cytotoxic enhancement in H460 lung carcinoma cells compared to cisplatin.
    Cancer chemotherapy and pharmacology, 2005, Volume: 56, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cisplatin; DNA Adducts;

2005
Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice.
    Cancer research, 2007, Apr-01, Volume: 67, Issue:7

    Topics: Administration, Oral; Animals; Anticarcinogenic Agents; Benzo(a)pyrene; Cell Growth Processes; Femal

2007
[Determinations of catalase in urine and its significance for clinical procedures].
    Arztliche Forschung, 1966, Sep-10, Volume: 20, Issue:9

    Topics: Adenocarcinoma; Catalase; Cystitis; Glomerulonephritis; Glycerol; Hepatitis; Humans; Hydrogen Peroxi

1966
Potential carcinostatic agents. I. Derivatives and analogs of 1-(2-hydroxyethyl)-3-(4-tolyl)urea.
    Journal of medicinal chemistry, 1967, Volume: 10, Issue:4

    Topics: Animals; Carcinoma; Chemistry, Organic; Leukemia L1210; Lung Neoplasms; Mice; Neoplasms, Experimenta

1967
A cytochemical study of lactic dehydrogenase (LDH) isoenzymes in human lung cancer.
    Cancer detection and prevention, 1984, Volume: 7, Issue:2

    Topics: Adenocarcinoma; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Histocytochemistry; Humans; Isoenzy

1984
Tumor induction by a single subcutaneous injection of 1-butyl-1-nitrosourea or 1-butylurea in newborn mice.
    Cancer letters, 1983, Volume: 18, Issue:3

    Topics: Adenocarcinoma; Adenoma; Animals; Animals, Newborn; Carcinogens; Female; Injections, Subcutaneous; L

1983
Total energy expenditure in patients with small-cell lung cancer: results of a validated study using the bicarbonate-urea method.
    Metabolism: clinical and experimental, 1997, Volume: 46, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Alkaline Phosphatase; Bicarbonates; Bilirubin;

1997
Induction of mouse lung adenomas by amines or ureas plus nitrite and by N-nitroso compounds: effect of ascorbate, gallic acid, thiocyanate, and caffeine.
    Journal of the National Cancer Institute, 1975, Volume: 55, Issue:3

    Topics: Adenoma; Amines; Animals; Ascorbic Acid; Caffeine; Dose-Response Relationship, Drug; Gallic Acid; Lu

1975
Large bowel carcinogenesis in mice and rats by several intrarectal doses of methylnitrosourea and negative effect of nitrite plus methylurea.
    Cancer research, 1976, Volume: 36, Issue:2 Pt 1

    Topics: Adenocarcinoma; Adenoma; Animals; Carcinoma, Squamous Cell; Colonic Neoplasms; Dose-Response Relatio

1976
DNA damage and differential cytotoxicity produced in human carcinoma cells by CC-1065 analogues, U-73,975 and U-77,779.
    Cancer research, 1991, Dec-15, Volume: 51, Issue:24

    Topics: Antibiotics, Antineoplastic; Benzofurans; Carcinoma; Cell Death; Colonic Neoplasms; Cross-Linking Re

1991
A statistical search for a routine laboratory tumor marker for lung cancer.
    Clinical chemistry, 1986, Volume: 32, Issue:2

    Topics: Aged; Blood Glucose; Electrolytes; Humans; L-Lactate Dehydrogenase; Lipids; Lung Neoplasms; Middle A

1986
Antibodies to 5 M urea soluble chromosomal proteins from HeLa cells.
    Biochimica et biophysica acta, 1985, Jan-28, Volume: 838, Issue:1

    Topics: Animals; Antibodies; Antibody Specificity; Antigens; Cell Line; Chromatin; Chromosomal Proteins, Non

1985
[Production of stomach and pancreatic cancer in the guinea pig using methylnitroso-urea and methylnitroso-urethane].
    Zeitschrift fur Krebsforschung, 1968, Volume: 71, Issue:2

    Topics: Animals; Body Weight; Carcinoma; Ear Neoplasms; Guinea Pigs; Laryngeal Neoplasms; Leukemia; Lung Neo

1968
Azathioprine (Imuran) administration and the development of malignant lymphomas in NZB mice.
    Clinical and experimental immunology, 1968, Volume: 3, Issue:4

    Topics: Albuminuria; Anemia, Hemolytic, Autoimmune; Animals; Azathioprine; Coombs Test; Glomerulonephritis;

1968
Toxicity, tissue changes, and tumor induction in inbred Swiss mice by methylnitrosamine and -amide compounds.
    Cancer research, 1970, Volume: 30, Issue:1

    Topics: Adenoma; Animals; Animals, Newborn; Blood Cell Count; Bone Marrow; Bone Marrow Cells; Carcinoma, Hep

1970
Carcinogenicity of a single administration of N-nitrosomethylurea: a comparison between newborn and 5-week-old mice and rats.
    British journal of cancer, 1970, Volume: 24, Issue:3

    Topics: Adenoma; Animals; Animals, Newborn; Carcinogens; Carcinoma, Hepatocellular; Female; Gastrointestinal

1970
[The cancer-risk in man from synthetic sweetening agents].
    La Presse medicale, 1971, Mar-13, Volume: 79, Issue:13

    Topics: Animals; Carcinoma, Hepatocellular; Cyclamates; Female; Liver Neoplasms; Lung Neoplasms; Lymphoma, N

1971
Demonstration of collagen in human tissues by immunofluorescence.
    Laboratory investigation; a journal of technical methods and pathology, 1972, Volume: 27, Issue:1

    Topics: Animals; Antigens; Breast; Breast Neoplasms; Collagen; Fluorescent Antibody Technique; Guanidines; H

1972
Production of the placental-type alkaline phosphatase isoennzyme by lung cancer tissue.
    Gan, 1972, Volume: 63, Issue:2

    Topics: Adenocarcinoma; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Cysteine; E

1972
[Research on the medical consequences of tobacco use in Black Africa].
    Bulletin de la Societe medicale d'Afrique noire de langue francaise, 1974, Volume: 19, Issue:1

    Topics: Adolescent; Adult; Black People; Blood Glucose; Blood Pressure; Child; Cholesterol; Humans; Lung Neo

1974
Clinical evaluation of the adjunctive use of hydroxyurea (NSC-32065) in radiation therapy of carcinoma of the lung. A comparative study.
    Radiologia clinica et biologica, 1967, Volume: 36, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Female; Humans; Hydroxyurea

1967
Nitrosamide formation in vivo: induction of lung adenomas in Swiss mice by concurrent feeding of nitrite and methylurea or ethylurea.
    Journal of the National Cancer Institute, 1972, Volume: 48, Issue:5

    Topics: Adenocarcinoma; Adenoma; Animals; Carcinogens; Female; Kinetics; Lung Neoplasms; Lymphoma; Male; Mic

1972
Success and failure in the treatment of solid tumors. 3. "Cure" of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95442) and surgery-chemotherapy.
    Cancer chemotherapy reports, 1972, Volume: 56, Issue:2

    Topics: Animals; Antineoplastic Agents; Carcinoma; Carmustine; Cell Line; Cyclohexanes; Cyclophosphamide; Lu

1972
Structure-activity relationships: nitrosoureas.
    Cancer chemotherapy reports. Part 3, 1972, Volume: 3, Issue:1

    Topics: Animals; Antineoplastic Agents; Leukemia L1210; Lung Neoplasms; Nitroso Compounds; Nitrosourea Compo

1972
[Connective tissue changes in organ cultures of embryonic rat lung following the transplacental action of nitrosomethyl urea].
    Voprosy onkologii, 1971, Volume: 17, Issue:7

    Topics: Animals; Connective Tissue; Female; Lung; Lung Neoplasms; Maternal-Fetal Exchange; Neoplasms, Experi

1971
Induction of neurosarcoma by injections of N-nitrosobutylurea in suckling Syrian golden hamsters.
    Experientia, 1971, Dec-15, Volume: 27, Issue:12

    Topics: Abdominal Neoplasms; Age Factors; Animals; Cricetinae; Fibrosarcoma; Lung Neoplasms; Lymphatic Metas

1971
Tumour induction by low molecular weight alkylating agents.
    Chemico-biological interactions, 1971, Volume: 3, Issue:2

    Topics: Adenoma; Alkanes; Alkylating Agents; Animals; Carcinogens; DNA Replication; DNA, Neoplasm; Guanine;

1971
[Use of N-nitroso methylurea in lung cancer].
    Voprosy onkologii, 1971, Volume: 17, Issue:11

    Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Female; Humans; Lung Neoplasms; Male; Middle

1971
[Precancerous epithelial changes, induced by the transplacental action of nitrosomethyl urea, in organ cultures of rat embryonic lung tissue].
    Voprosy onkologii, 1971, Volume: 17, Issue:11

    Topics: Animals; Female; Lung Neoplasms; Maternal-Fetal Exchange; Nitroso Compounds; Nitrosourea Compounds;

1971
Immunologic and biochemical approaches to alkaline phosphatase isoenzyme analysis: the Regan isoenzyme.
    Annals of the New York Academy of Sciences, 1969, Oct-14, Volume: 166, Issue:2

    Topics: Alkaline Phosphatase; Animals; Antigen-Antibody Reactions; Blood Protein Electrophoresis; Bone and B

1969
The importance of varying molecular size, differential heat and urea inactivation of phosphatase in the identification of disease patterns.
    Annals of the New York Academy of Sciences, 1969, Oct-14, Volume: 166, Issue:2

    Topics: Adult; Alkaline Phosphatase; Biliary Tract Diseases; Breast Neoplasms; Carcinoma; Chemical Phenomena

1969
Pharmacological enhancement and short-term stimulation of blood fibrinolytic activity.
    Scandinavian journal of haematology, 1969, Volume: 6, Issue:6

    Topics: Adolescent; Adult; Aged; Aminocaproates; Anticholesteremic Agents; Arteriosclerosis; Arthritis, Rheu

1969
[Transplacental effect of blastomogenic substances. Some further studies on organ cultures].
    Arzneimittel-Forschung, 1969, Volume: 19, Issue:7

    Topics: Adenoma; Animals; Benz(a)Anthracenes; Biphenyl Compounds; Carcinogens; Culture Techniques; Embryo, M

1969
Combination chemotherapy in malignant melanoma.
    Cancer, 1970, Volume: 26, Issue:2

    Topics: Adult; Bone Marrow Examination; Bone Neoplasms; Brain Neoplasms; Female; Hemoglobins; Humans; Inject

1970
Tissue-dependent differences in DNA methylation products of mice treated with methyl-labelled methylnitrosourea.
    International journal of cancer, 1971, May-15, Volume: 7, Issue:3

    Topics: Adenine; Adenoma; Animals; Bone Marrow; Carbon Isotopes; DNA, Neoplasm; Guanine; Kidney; Liver; Lung

1971
Carcinogenicity of 1-methyl-1-nitrosourea in newborn mice and rats.
    Journal of the National Cancer Institute, 1968, Volume: 41, Issue:3

    Topics: Animals; Animals, Newborn; Carcinogens; Injections, Subcutaneous; Kidney Neoplasms; Leukemia, Experi

1968
[Postoperative changes in the water-salt balance in patients undergoing surgery in connection with diseases of organs of the chest cavity].
    Vestnik khirurgii imeni I. I. Grekova, 1968, Volume: 101, Issue:7

    Topics: Cardiac Surgical Procedures; Chlorides; Creatinine; Esophageal Neoplasms; Hematuria; Humans; Inflamm

1968
Carcinogenic effect of N-methyl-N-nitrosourea administered subcutaneously to Syrian hamsters.
    The Journal of pathology and bacteriology, 1966, Volume: 92, Issue:1

    Topics: Animals; Carcinogens; Cricetinae; Hematopoietic System; Hyperplasia; Injections, Subcutaneous; Lung

1966